Train with experienced instructors who support, guide, and empower you to succeed.
Training and learning delivered is safe, regulated, evidence-based, and quality assured.
All participants receive a Certificate on Completion, providing audit-ready evidence of learning.
Evening master classes available Quick and easy registration Training provided weekly
Practical, non-promotional education designed for real community pharmacy settings, supporting safe GLP-1 use and escalation awareness.
NovoVital is a UK-based digital health innovation designed to improve the safety, governance, and sustainability of GLP-1 weight management support through community pharmacy.
As GLP-1 medicines become more widely used, there is a growing need for consistent follow-up, structured monitoring, and clear escalation pathways to support safe long-term use. NovoVital exists to bridge this gap—supporting both pharmacy teams and patients with practical tools that fit real-world care.
NOVOVITAL LTD is registered in England and Wales and is led by a Clinical Pharmacist and a researcher with a clear ambition for evidence-led innovation in healthcare.
A patient-only self-monitoring tool that encourages symptom awareness and appropriate escalation when patients feel
Training built around consistent team messaging, documentation awareness, and risk reduction—supporting professional accountability.
Our mission is to support safer, more consistent weight management services by enabling
GLP-1 medicines are increasingly used in weight management, and community pharmacy teams are often the first point of contact for patient questions, side effects, and ongoing support. This training helps ensure consistent counselling, safe escalation awareness, and governance-led ways of working—supporting patient safety and reducing risks to the pharmacy.
Yes. NovoVital provides free clinical training to participating community pharmacies. - 1st 6 Months
NovoVital will draft a patient report for the pharmacy manager at 6 months to support governance review. This helps the pharmacy team assess progress and document review against NICE continuation expectations (including at least 5% weight loss at 6 months).
Management or manager's approval is not compulsory
No. Patient use of the self-monitoring support tool is optional and can be offered where appropriate.
No. NovoVital does not provide diagnosis, prescribing decisions, or medical advice. It supports safe monitoring, education, and escalation where appropriate.
